Research/art/teacher profile of a person
Name and surname:
prof. PharmDr. Tomáš Tesař, PhD., MBA
Document type:
Research/art/teacher profile of a person
The name of the university:
Comenius University Bratislava
The seat of the university:
Šafárikovo námestie 6, 818 06 Bratislava

I. - Basic information

I.1 - Surname
Tesař
I.2 - Name
Tomáš
I.3 - Degrees
Prof., PharmDr., PhD., MBA, MPH
I.4 - Year of birth
1973
I.5 - Name of the workplace
Department of Organization and Management of Pharmacy, Faculty of Pharmacy, Comenius University, Bratislava
I.6 - Address of the workplace
Odbojárov 10, 832 32 Bratislava, Slovensko
I.7 - Position
Professor
I.8 - E-mail address
tesar@fpharm.uniba.sk
I.9 - Hyperlink to the entry of a person in the Register of university staff
https://www.portalvs.sk/regzam/detail/20451
I.10 - Name of the study field in which a person works at the university
Pharmacy
I.11 - ORCID iD
https://orcid.org/0000-0002-0023-4574

II. - Higher education and further qualification growth

II.1 - First degree of higher education
II.2 - Second degree of higher education
II.a - Name of the university or institution
Faculty of Pharmacy, Comenius University, Bratislava, Slovakia
II.b - Year
1996
II.c - Study field and programme
Pharmacy
II.3 - Third degree of higher education
II.a - Name of the university or institution
Faculty of Pharmacy, Comenius University, Bratislava, Slovakia
II.b - Year
2002
II.c - Study field and programme
Social Pharmacy - Retail Pharmacy
II.4 - Associate professor
II.a - Name of the university or institution
Faculty of Pharmacy, Comenius University, Bratislava, Slovakia
II.b - Year
2009
II.c - Study field and programme
Retail Pharmacy - Social Pharmacy
II.5 - Professor
II.a - Name of the university or institution
Faculty of Pharmacy, Comenius University, Bratislava, Slovakia
II.b - Year
2024
II.c - Study field and programme
Clinical pharmacy
II.6 - Doctor of Science (DrSc.)

III. - Current and previous employment

III.a - Occupation-position III.b - Institution III.c - Duration
Professor Faculty of Pharmacy, Comenius University, Bratislava, Slovakia from 01.09.2024
Associate Professor Faculty of Pharmacy, Comenius University, Bratislava, Slovakia from 2014
Associate Professor The University of Veterinary Medicine and Pharmacy in Košice from 09/2013 to 11/2013
Member of the Reimbursement Committee for Drugs on behalf of Union Health Insurance Fund Union Health Insurance Fund from 2008
Assistant Professor Faculty of Pharmacy, Comenius University, Bratislava, Slovakia od 2003 do 2010
Pharmacist Pharmacy Thomas, Nám. Slobody 23, Bratislava from 1996 to 2006
Manager Byk Gulden GmbH from 1996 to 2002

IV. - Development of pedagogical, professional, language, digital and other skills

IV.a - Activity description, course name, other IV.b - Name of the institution IV.c - Year
The Master of Public Health (MPH) degree Slovak Medical University in Bratislava, Slovakia 2017
Master's Degree Diploma in Health Technology Assessment and Management Università Cattolica del Sacro Cuore, Roma, Italy 2016
Certificate for Revision Pharmacy Slovak Medical University in Bratislava, Slovakia 2014
Health Outcomes Research Diploma Vienna School of Clinical Research, Vienna, Austria 2008
The Postgraduate Certificate in Health economics for health care professionals University of York, UK 2008
Master of Business Administration The Open University, Milton Keynes, UK 2007
Certificate for Pharmacoeconomics Slovak Medical University in Bratislava, Slovakia 2006
Specialization in Pharmacy I. Grade Slovak Postgraduate Academy of Medicine 1999
The International English Language Testing System (IELTS) English Language School, St Giles International, London, UK 2001

V. - Overview of activities within the teaching career at the university

V.1 - Overview of the profile courses taught in the current academic year according to study programmes
V.1.a - Name of the profile course V.1.b - Study programme V.1.c - Degree V.1.d - Field of study
Social Pharmacy and Retail Pharmacy Pharmacy Master's Pharmacy
V.2 - Overview of the responsibility for the delivery, development and quality assurance of the study programme or its part at the university in the current academic year
V.3 - Overview of the responsibility for the development and quality of the field of habilitation procedure and inaugural procedure in the current academic year
V.4 - Overview of supervised final theses
V.4.1 - Number of currently supervised theses
V.4.b - Diploma (second degree)
7
V.4.c - Dissertation (third degree)
5
V.4.2 - Number of defended theses
V.4.a - Bachelor's (first degree)
3
V.4.b - Diploma (second degree)
55
V.4.c - Dissertation (third degree)
2
V.5 - Overview of other courses taught in the current academic year according to study programmes
V.5.a - Name of the course V.5.b - Study programme V.5.c - Degree V.5.d - Field of study
Social Pharmacy and Pharmacoeconomics Pharmacy Master Study Pharmacy
Computer Data Processing Pharmacy Master Study Pharmacy
Pharmaceutical Propedeutics Pharmacy Master Study Pharmacy
Pharmaceutical Informatics Pharmacy Master Study Pharmacy
Health Technology Assessment Pharmacy Master Study Pharmacy

VI. - Overview of the research/artistic/other outputs

VI.1 - Overview of the research/artistic/other outputs and the corresponding citations
VI.1.1 - Number of the research/artistic/other outputs
VI.1.a - Overall
195
VI.1.b - Over the last six years
91
VI.1.2 - Number of the research/artistic/other outputs registered in the Web of Science or Scopus databases
VI.1.a - Overall
44
VI.1.b - Over the last six years
38
VI.1.3 - Number of citations corresponding to the research/artistic/other outputs
VI.1.a - Overall
295
VI.1.b - Over the last six years
103
VI.1.4 - Number of citations registered in the Web of Science or Scopus databases
VI.1.a - Overall
269
VI.1.b - Over the last six years
101
VI.1.5 - Number of invited lectures at the international, national level
VI.1.a - Overall
5
VI.1.b - Over the last six years
5
VI.2 - The most significant research/artistic/other outputs
1

Grigoryan, Larissa - Haaijer-Ruskamp, Flora M. - Burgerhof, Johannes G. M. - Mechtler, Reli - Deschepper, Reginald - Tambic-Andrasevic, Arjana - Andrajati, Retnosari - Monnet, Dominique L. - Cunney, Robert - Matteo, Antonella di - Edelstein, Hana - Valinteliene, Rolanda - Alkerwi, Alaa - Scicluna, Elizabeth A. - Grzesiowski, Pawel - Bara, Ana-Claudia - Tesař, Tomáš [UKOFAPR] - Cizman, Milan - Campos, Jose - Lundborg, Cecilia Stalsby - Birkin, Joan: Self-medication with antimicrobial drugs in Europe

In: Emerging Infectious Diseases. - Vol. 12, No. 3 (2006), s. 452-459. - ISSN 1080-6059

2

Wawruch, Martin [KAUT] [UKOLFFAU] (18%) - Zaťko, Dušan (9%) - Wimmer, Gejza, ml. (9%) - Luha, Ján [UKOLF] (9%) - Kuželová, Lenka (9%) - Kukumberg, Peter [UKOLF] (9%) - Murín, Ján [UKOLF1IK] (9%) - Hlôška, Adam (9%) - Kállay, Zoltán [UKOLF] (9%) - Shah, Rashmi (1%) - Tesař, Tomáš [UKOFAPR] (9%): Factors influencing non-persistence with antiplatelet medications in elderly patients after ischaemic stroke

In: Drugs & Aging. - Vol. 33, No. 5 (2016), s. 365-373. - ISSN 1170-229X

Registrované v: wos, scopus

Indikátor časopisu: IF (JCR) 2016=2,769

3

Wawruch, Martin [KAUT] [UKOLFFAU] (40%) - Zaťko, Dušan (4%) - Wimmer, Gejza, ml. (5%) - Luha, Ján [UKOLF] (10%) - Hricák, Vasiľ [UKOLFFAU] (5%) - Murín, Ján [UKOLF1IK] (10%) - Kukumberg, Peter (10%) - Tesař, Tomáš [UKOFAPR] (10%) - Hlôška, Adam(5%) - Shah, Rashmi (1%): Patient-related characteristics associated with non-persistence with statin therapy in elderly patients following an ischemic stroke

In: Pharmacoepidemiology and Drug Safety. - Vol. 26, No. 2 (2017), s. 201-207. - ISSN 1053-8569

Registrované v: wos, scopus

Indikátor časopisu: IF (JCR) 2017=2,314

4

Haramiová, Zuzana [KAUT] [UKOFAPR] (45%) - Staško, Michal (5%) - Hulín, Martin (5%) - Tesař, Tomáš [UKOFAPR] (20%) - Kuželová, Magdaléna [UKOFAFT] (20%) - Morisky, Donald M. (5%): The effectiveness of daily SMS reminders in pharmaceutical care ofolder adults on improving patients adherence to antihypertensive medication (SPPA): study protocol for a randomized controlled trial

In: Trials. - Vol. 18 (2017), s. 334-334 [15s.]. - ISSN 1745-6215

5

Kawalec, Pawel (10%) - Tesař, Tomáš [UKOFAPR] (6%) - Vostalová, Lenka (6%) - Draganic, Pero (6%) - Manová, Manoela (6%) - Savova, Alexandra (6%) - Petrova, Guenka (6%) - Rugaja, Zinta (6%) - Männik, Agnes (6%) - Sowada, Christoph (6%) - Stawowczyk,Ewa (6%) - Harsányi, András (6%) - Inotai, András (6%) - Turcu-Stiolica, Adina (6%) - Gulbinovic, Jolanta (6%) - Pilc, Andrzej (6%): Pharmaceutical regulation in Central and Eastern European countries: A current review

In: Frontiers in Pharmacology. - Vol. 8, art. no. 892 (2017), nestr. [16 s.]. - ISSN 1663-9812

Registrované v: wos, scopus

Indikátor časopisu: IF (JCR) [2016-4,400]

VI.3 - The most significant research/artistic/other outputs over the last six years
1

Tesar T, Szilberhorn L, Nemeth B, Nagy B, Wawruch M and Kalo Z (2017) Cost-Utility Analysis of Heberprot-P as an Add-on Therapy to Good Wound Care for Patients in Slovakia with Advanced Diabetic Foot Ulcer. Front. Pharmacol. 8:946. doi: 10.3389/fphar.2017.00946

2

Tesar T, Obsitnik B, Kaló Z and Kristensen FB (2019) How Changes in Reimbursement Practices Influence the Financial Sustainability of Medicine Policy: Lessons Learned from Slovakia. Front. Pharmacol. 10:664. doi: 10.3389/fphar.2019.00664

3

Tesar T, Golias P, Kobliskova Z, Wawruch M, Kawalec P and Inotai A (2020) Potential Cost-Savings From the Use of the Biosimilars in Slovakia. Front. Public Health 8:431. doi: 10.3389/fpubh.2020.00431

4

Tesar T, Masarykova L, Lehocka L, Porubcova S, Cicova M, Wawruch M. Consumption of Antibacterials for Systemic Use in Slovakia: A National Study and the Quality Indicators for Outpatient Antibiotic Use. Antibiotics. 2021; 10(10):1180. https://doi.org/10.3390/antibiotics10101180

5

Tesar T, Golias P, Masarykova L, Kawalec P and Inotai A (2021) The Impact of Reimbursement Practices on the Pharmaceutical Market for Off-Patent Medicines in Slovakia. Front. Pharmacol. 12:795002. doi: 10.3389/fphar.2021.795002

VI.4 - The most significant citations corresponding to the research/artistic/other outputs
1

[o1] 2007 Gul, H. - Omurtag, G. - Clark, P. M. - Tozan, A. - Ozel, S.: Medical Science Monitor, Vol. 13, No. 7, 2007, PH14 - SCI

[o1] 2007 Campos, J. - Ferech, M. - Lazaro, E. - de Abajo, F. - Oteo, J. - Stephens, P. - Goossens, H.: Journal of Antimicrobial Chemotherapy, Vol. 60, No. 3, 2007, s. 701 - SCI

[o1] 2007 Matuz, M. - Benko, R. - Doro, P. - Hajdu, E. - Soos, G.: Pharmacy World & Science, Vol. 29, No. 6, 2007, s. 698 - SCI

[o1] 2007 Esimone, C. O. - Nworu, C. S. - Udeogaranya, O. P.: Pharmacy World & Science, Vol. 29, No. 6, 2007, s. 660 - SCI

[o1] 2007 Dar-Odeh, N. S. - Abu-Hammad, O. A. - Khraisat, A. S. - El Maaytah, M. A. - Shehabi, A.: Chemotherapy, Vol. 54, No. 1, 2007, s. 22 - SCI

[o1] 2009 Gasink, L.B. - Linkin, D.R. - Fishman, N.O. - Bilker, W.B. - Weiner, M.G. - Lautenbach, E.: Infection Control and Hospital Epidemiology, Vol. 30, No. 4, 2009, s. 376 - SCI

[o1] 2006 Kardas, P.: FAmily Medicine and Primary Care Review, Vol. 8, No. 3, 2006, s. 954 - SCOPUS

[o1] 2006 González, J. - Orero, A. - Prieto, J.: Revista Espanola de Quimiterapia, Vol. 19, No. 3, 2006, s. 285 - SCOPUS

[o1] 2014 Cheaito, L. - Azizi, S. - Saleh, N. - Salameh, P.: International Journal of Public Health, Vol. 59, No. 2, 2014, s. 327 - SCOPUS

[o1] 2014 Gül, S. - Öztürk, D.B. - Yilmaz, M.S. - Uz-Gül, E.: Turk Hijyen ve Deneysel Biyoloji Dergisi, Vol. 71, No. 3, 2015, s. 112 - SCOPUS

[o1] 2014 Tejashree, T. - Sarala, N. - Girish, G.M.: Research Journal of Pharmaceutical, Biological and Chemical Sciences, Vol. 5, No. 1, 2014, s. 218 - SCOPUS

[o1] 2014 Belkina, T. - Al Warafi, A. - Hussein Eltom, E. - Tadjieva, N. - Kubena, A. - Vlcek, J.: Journal of Infection in Developing Countries, Vol. 8, No. 4, 2014, s. 429 - SCOPUS

[o1] 2014 Jasim, A.L.: International Journal of Pharmacy and Pharmaceutical Sciences, Vol. 6, No. 10, 2014, s. 489 - SCOPUS

[o1] 2014 Papakosta, M. - Zavras, D. - Niakas, D.: Rural and Remote Health, Vol. 14, No. 2, 2014, art. no. 2349 - SCOPUS

[o1] 2014 Munoz, E.B. - Dorado, M.F. - Guerrero, J.E. - Martínez, F.M.: Atencion Primaria, Vol. 46, No. 7, 2014, s. 375 - SCOPUS

[o1] 2014 Machado-Alba, J.E. - Echeverri-Catano, L.F. - Londono-Builes, M.J. - Moreno-Gutiérrez, P.A. - Ochoa-Orozco, S.A. - Ruiz-Villa, J.O.: Biomedica, Vol. 34, No. 4, 2014, s. 588 - SCOPUS

[o1] 2014 Jorgji, K. - Bebeci, E. - Apostoli, P. - Apostoli, A.: Hippokratia, Vol. 18, No. 3, 2014, s. 220 - SCOPUS

[o1] 2014 Borg, M.A.: Journal of Hospital Infection, Vol. 86, No. 3, 2014, s. 168 - SCOPUS

[o1] 2014 Dimova, R.T. - Dimitrova, D. - Semerdjieva, M. - Doikov, I.: Macedonian Journal of Medical Sciences, Vol. 7, No. 4, 2014, s. 661 - SCOPUS

[o1] 2014 Ramalhinho, I. - Cordeiro, C. - Cavaco, A. - Cabrita, J.: International Journal of Clinical Pharmacy, Vol. 36, No. 5, 2014, s. 1047 - SCOPUS

[o1] 2014 Hamoen, M. - Broekhuizen, B.D.L. - Little, P. - Melbye, H. - Coenen, S. - Goossens, H. - Butler, C.C. - Francis, N.A. - Verheij, T.J.M.: British Journal of General Practice, Vol. 64, No. 619, 2014, s. e91 - SCOPUS

[o1] 2014 Yu, M. - Zhao, G. - Stalsby Lundborg, C. - Zhu, Y. - Zhao, Q. - Xu, B.: BMC Infectious Diseases, Vol. 14, No. 1, 2014, art. no. 112 - SCOPUS

[o1] 2014 Rashwan, Z.I. - Waziry, O.G. - Sabry, Y.Y.: Life Science Journal, Vol. 11, No. 4, art. no. 2, 2014, 17-36 - SCOPUS

[o1] 2014 Bilcke, J. - Coenen, S. - Beutels, P.: PLoS ONE, Vol. 9, No. 7, 2014, art. no. e102634 - SCOPUS

[o1] 2014 Biswas, M. - Roy, M.N. - Manik, M.I.N. - Hossain, M.S. - Tapu, S.T.A. - Moniruzzaman, M. - Sultana, S.: BMC Public Health, Vol. 14, No. 1, 2014, art. no. 847 - SCOPUS

[o1] 2015 Farah, R. - Lahoud, N. - Salameh, P. - Saleh, N.: Journal of Infection and Public Health, Vol. 8, No. 1, 2014, s. 46 - SCOPUS

[o1] 2015 Roque, F. - Soares, S. - Breitenfeld, L. - Figueiras, A. - Herdeiro, M.T.: Clinical Therapeutics, Vol. 37, No. 1, 2015, s. 177 - SCOPUS

[o1] 2015 Mansouri, A. - Sarayani, A. - Ashouri, A. - Sherafatmand, M. - Hadjibabaie, M. - Gholami, K.: PLoS ONE, Vol. 10, No. 5, 2015, art. no. e0125093 - SCOPUS

[o1] 2011 Schjorring, S. - Krogfelt, K.A.: International Journal of Microbiology, 2011, art. no. 312956 - SCOPUS

[o1] 2011 Le, T.H. - Ottosson, E. - Nguyen, T.K.C. - Kim, B.G. - Allebeck, P.: Journal of Multidisciplinary Healthcare, Vol. 4, 2011, s. 336 - SCOPUS

[o1] 2011 Widayati, A. - Suryawati, S. - De Crespigny, C. - Hiller, J.E.: BMC Research Notes, Vol. 4, 2011, art. no. 491 - SCOPUS

[o1] 2011 Krcmery, V.: Future Microbiology, Vol. 6, No. 12, 2011, s. 1394 - SCOPUS

[o1] 2011 Zarb, P. - Borg, M.A.: Malta Medical Journal, Vol. 23, No. 2, 2011, s. 18 - SCOPUS

[o1] 2012 Zarb, P. - Goossens, H.: OIE Revue Scientifique et Technique, Vol. 31, No. 1, 2012, s. 133 - SCOPUS

[o1] 2012 González-Martínez, R. - Cortell-Ballester, I. - Herráez-Vilas, J.M. - Arnau-de Bolós, J.M. - Gay-Escoda, C.: Medicina Oral, Patologia Oral y Cirugia Bucal, Vol. 17, No. 3, 2012, s. e456 - SCOPUS

[o1] 2012 Dameh, M. - Norris, P. - Green, J.: Journal of Primary Health Care, Vol. 4, No. 2, 2012, s. 140 - SCOPUS

[o1] 2012 Pan, H. - Cui, B. - Zhang, D. - Farrar, J. - Law, F. - Ba-Thein, W.: PLoS ONE, Vol. 7, No. 7, 2012, art. no. e41314 - SCOPUS

[o1] 2012 Marković-Peković, V. - Grubiša, N.: Pharmacoepidemiology and Drug Safety, Vol. 21, No. 10, 2012, s.1133 - SCOPUS

[o1] 2012 Wun, Y.T. - Lam, T.P. - Lam, K.F. - Sun, K.S.: International Journal of Clinical Practice, Vol. 66, No. 12, 2012, s. 1203 - SCOPUS

[o1] 2012 Askarian, M. - Maharlouie, N.: International Journal of Preventive Medicine, Vol. 3, No. 12, 2012, s. 845 - SCOPUS

[o1] 2012 Khalaf, N.G. - Hanson, N.D.: Multidrug Resistance A Global Concern, 2012, s. 205 - SCOPUS

[o1] 2013 Wun, Y.T. - Lam, T.P. - Lam, K.F. - Ho, P.L. - Yung, W.H.R.: Pharmacoepidemiology and Drug Safety, Vol. 22, No. 3, 2013, s. 249 - SCOPUS

[o1] 2013 Yu, M. - Zhu, Y.P. - Song, X.X. - Yang, L. - Tao, T. - Zhao, Q. - Xu, B. - Zhao, G.M.: Fudan University Journal of Medical Sciences, Vol. 40, No. 3, 2013, s. 258 - SCOPUS

[o1] 2013 Kumar, N. - Kanchan, T. - Unnikrishnan, B. - Rekha, T. - Mithra, P. - Kulkarni, V. - Papanna, M.K. - Holla, R. - Uppal, S.: PLoS ONE, Vol. 8, No. 8, 2013, art. no. e72247 - SCOPUS

[o1] 2013 Gastelurrutia, M.A. - Larranaga, B. - Garay, A. - Echeveste, F.A. - Fernandez-Llimos, F.: Pharmacy Practice, Vol. 11, No. 4, 2013, s. 190 - SCOPUS

[o1] 2013 Muras, M. - Krajewski, J. - Nocun, M. - Godycki-Cwirko, M.: Archives of Medical Science, Vol. 9, No. 5, 2013, s. 857 - SCOPUS

[o1] 2013 Koley, M. - Saha, S. - Ghosh, A. - Ganguly, S. - Arya, J.S. - Choubey, G.: International Journal of High Dilution Research, Vol. 12, No. 45, 2013, s. 189 - SCOPUS

[o1] 2013 Napolitano, F. - Izzo, M.T. - Di Giuseppe, G. - Angelillo, I.F.: PLoS ONE, Vol. 8, No. 12, 2013, art. no. e84177 - SCOPUS

[o1] 2010 Holloway, K.A.: Expert Review of Clinical Pharmacology, Vol. 4, No. 3, 2011, s. 348 - SCOPUS

[o1] 2010 Togoobaatar, G. - Ikeda, N. - Ali, M. - Sonomjamts, M. - Dashdemberel, S. - Mori, R. - Shibuya, K.: Bulletin of the World Health Organization, Vol. 88, No. 12, 2010, s. 936 - SCOPUS

[o1] 2010 Kosar, Y. - Sunay, D. - Cebeci, S.: Cocuk Sagligi ve Hastaliklari Dergisi, Vol. 53, No. 4, 2010, s. 290 - SCOPUS

[o1] 2010 Delgado Sánchez, O. - Palomo, J.B. - Ortega, M.S. - Ribas, F.M.: Enfermedades Infecciosas y Microbiologia Clinica, Vol. 28, Suppl. 4, 2010, s. 39 - SCOPUS

[o1] 2010 Ruiz, M.E.: Current Drug Safety, Vol. 5, No. 4, 2010, s. 323 - SCOPUS

[o1] 2010 Dameh, M. - Green, J, - Norris, P.: Phyrmacy World and Science, Vol. 32, No. 5, 2010, s. 650 - SCOPUS

[o1] 2010 Jiménez-Rubio, D. - Hernández-Quevedo, C.: Health Policy, Vol. 97, No. 2-3, 2010, s. 224 - SCOPUS

[o1] 2010 Davey, P. - Sneddon, J. - Nathwani, D.: Expert Review of Clinical Pharmacology, Vol. 3, No. 5, 2010, s. 686 - SCOPUS

[o1] 2010 Skliros, E. - Merkouris, P. - Papazafiropoulou, A. - Gikas, A. - Matzouranis, G. - Papafragos, C. - Tsakanikas, I. - Zarbala, I. - Vasibosis, A. - Stamataki, P. - Sotiropoulos, A.: BMC Family Practice, Vol. 11, 2010, art.no. 58 -SCOPUS

[o1] 2010 Nalini, G.K.: British Journal of Medical Practitioners, Vol. 3, No. 2, 2010, s. 14 - SCOPUS

[o1] 2010 Gartin, M. - Brewis, A.A. - Schwartz, N.A.: Medical Anthropology Quarterly, Vol. 24, No. 1, 2010, s. 107 - SCOPUS

[o1] 2010 Šeputiene, V. - Povilonis, J. - Ružauskas, M. - Pavilonis, A. - Sužiedeliene, E.: Journal of Medical Microbiology, Vol. 59, No. 3, 2010, s. 322 - SCOPUS

[o1] 2010 Jiménez Rubio, D. - Hernández Quevedo, C.: Gaceta Sanitaria, Vol. 24, No. 2, 2010, s. 116.e8 - SCOPUS

[o1] 2010 Plachouras, D. - Kavatha, D. - Antoniadou, A. - Giannitsioti, E. - Poulakou, G. - Kanellakopoulou, K. - Giamarellou, H.: Eurosurveillance, Vol. 15, No. 7, 2010, s. 4 - SCOPUS

[o1] 2010 Markovic-Pekovic, V. - Stoisavljevic-Šatara, S. - Škrbic, R.: European Journal of Clinical Pharmacology, Vol. 66, No. 2, 2010, s. 186 - SCOPUS

[o1] 2010 Walter, J.K. - Lang, C.W. - Ross, L.F.: Journal of Medical Ethics, Vol. 36, No. 1, 2010, s. 23 - SCOPUS

[o1] 2010 Sarahroodi, S. - Arzi, A. - Sawalha, A.F. - Ashtarinezhad, A.: International Journal of Pharmacology, Vol. 6, No. 1, 2010, s. 52 - SCOPUS

[o1] 2007 Vázquez Fernández, M.E. - Luquero Alcalde, F.J. - Pastor García, E. - Bachiller Luque, M.R. - Vázquez Fernández, M.J. - Eiros Bouza, J.M.: Anales de Pediatria, Vol. 67, No. 1, 2007, s. 17 - SCOPUS

[o1] 2007 Reeves, D.: Journal of Antimicrobial Chemotherapy, Vol. 59, No. 3, 2007, s. 341 - SCOPUS

[o1] 2007 Al-Azzam, S.I. - Al-Husein, B.A. - Alzoubi, F. - Masadeh, M.M. - Al-Horani, M.A.S.: International Journal of Occupational Medicine and Environmental Health, Vol. 20, No. 4, 2007, s. 380 - SCOPUS

[o1] 2007 Andraševič, A.T.: Medicina, Vol. 43, No. 1, 2007, s. 14 - SCOPUS

[o1] 2007 Kardas, P. - Pechére, J.C. - Hughes, D.A. - Cornaglia, G.: International Journal of Antimicrobial Agents, Vol. 30, No. 6, 2007, s. 536 - SCOPUS

[o1] 2007 Loffler, C.A. - MacDougall, C.: Expert Review of Anti-Infective Therapy, Vol. 5, No. 6, 2007, s. 981 - SCOPUS

[o1] 2008 Wickström, K.: Acta Ophtalmologica, Vol. 86, No. 1, 2008, s. 4 - SCOPUS

[o1] 2008 Orueta, R. - Gómez-Calcerrada, R.M. - Sánchez, A.: Semergen, Vol. 34, No. 3, 2008, s. 137 - SCOPUS

[o1] 2008 De Bolle, L. - Mehuys, E. - Adriaens, E. - Remon, J.P. - Van Bortel, L. - Christiaens, T.: Annals of Pharmacotherapy, Vol. 42, No. 4, 2008, s. 579 - SCOPUS

[o1] 2008 Moranta Ribas, F. - Sitjar Garí, A. - Maroto Yagüe, A.I. - Sanz Guillén, M.A.: Pharmaceutical Care Espana, Vol. 10, No. 2, 2008, s. 62 - SCOPUS

[o1] 2008 Awad, A. - Al-Rabiy, S. - Abahussain, E.: Medical Principles and Practice, Vol. 17, No. 4 , 2008, s. 320 - SCOPUS

[o1] 2009 Gasink, L.B. - Linkin, D.R. - Fishman, N.O. - Bilker, W.B. - Weiner, M.G. - Lautenbach, E.: Infection Control and Hospital Epidemiology, Vol. 30, No. 4, 2009, s. 376 - SCOPUS

[o1] 2009 Llor, C. - Cots, J.M.: Clinical Infectious Diseases, Vol. 48, No. 10, 2009, s. 1349 - SCOPUS

[o1] 2009 Matuz, M. - Benko, R. - Doró, P. - Hajdú, E. - Soós, G.: Acta Pharmaceutica Hungarica, Vol. 79, No. 2, 2009, s.74 - SCOPUS

[o1] 2009 Dryden, M.S. - Cooke, J. - Dawey, P.: Journal of Antimicrobial Chemotherapy, Vol. 64, No. 5, 2009, s. 888 - SCOPUS

[o1] 2009 Sancho-Puchades, M. - Herráez-Vilas, J.M. - Valmaseda-Castellón, E. - Berini-Aytés, L. - Gay-Escoda, C.: Medicina Oral, Patologia Oral y Cirugia Bucal, Vol. 14, No. 10, 2009, s. e537 - SCOPUS

[o1] 2009 Nounou, B. - Cattáneo, M.E. - Salmón, R. - Palasezze, L. - Boccaleri, J. - Cestona, E. - Bedecarras, F. - Ranieri, F. Talevi, A. - Munoz, S.M.: Latin American Journal of Pharmacy, Vol. 28, No. 4, 2009, s. 551 - SCOPUS

[o1] 2009 Radoševic, N. - Vlahovcć-Palčevski, V. - Benko, R. - Peklar, J. - Miškulin, I. - Matuz, M. - Papaioannidou, P. -Sabo, A. - Palčevska-Koceska, S.: Pharmacoepidemiology and Drug Safety, Vol. 18, No. 8, 2009, s. 696 - SCOPUS

[o1] 2009 Walter, J.K. - Pappano, E. - Ross, L.F.: Journal of Clinical Ethics, Vol. 20, No. 4, 2009, s. 361 - SCOPUS

[o1] 2009 Sarahroodi, S. - Arzi, A.: Journal of Biological Sciences, Vol. 9, No. 8, 2009, s. 832 - SCOPUS

[o1] 2009 Abasaeed, A. - Vlcek, J. - Abuelkhair, M. - Kubena, A.: Journal of Infection in Developing Countries, Vol. 3, No. 7, 2009, s. 497 - SCOPUS

[o1] 2009 Gagliotti, C. - Mazzetti, I. - Moro, M.L.: Pharmacoepidemiology and Drug Safety, Vol. 18, No. 11, 2009, s. 1118 - SCOPUS

[o1] 2009 Ilhan, M.N. - Durukan, E. - Ilhan, S.O. - Aksakal, F.N. - Ozkan, S. - Bumin, M.A.: Pharmacoepidemiology and Drug Safety, Vol. 18, No. 12, 2009, s. 1157 - SCOPUS

2

[o1] 2017 Choi, K.H. - Yu, Y.M. - Ah, Y.M. - Chang, M.J. - Lee, J.Y.: BMC Cardiovascular Disorders, vol. 17, no. 1, 2017, art. no. 232 - SCI ; SCOPUS

[o1] 2017 Rohde, D. - Merriman, N.A. - Doyle, F. - Bennett, K. - Williams, D. - Hickey, A.: Plos One, vol. 12, no. 12, 2017, art. no. e0189339 - SCI ; SCOPUS

[o1] 2019 Chen, S.H. - Lee, H.C. - Chang, K.C. - Hung, J.W. - Chen, H.M. - Wu, C.Y. - Yang, C.L. - Huang, Y.C. - Wang, H.H.: Acta Neurologica Taiwanica, vol. 28, no. 4, 2019, s. 95-118 - SCOPUS

[o1] 2020 Jang, D.E. - Zuniga, J.A.: Neurological Research, vol. 42, no. 7, 2020, s. 537-546 - SCOPUS

3

[o1] 2017 Choi, K.H. - Yu, Y.M. - Ah, Y.M. - Chang, M.J. - Lee, J.Y.: BMC Cardiovascular Disorders, vol. 17, no. 1, 2017, art. no. 232 - SCI ; SCOPUS

[o1] 2017 Rohde, D. - Merriman, N.A. - Doyle, F. - Bennett, K. - Williams, D. - Hickey, A.: PLoS ONE, vol. 12, no. 12, 2017, art. no. e0189339 - SCI ; SCOPUS

[o1] 2018 Byrne, P. - Cullinan, J. - Murphy, C. - Smith, S.M.: BMJ Open, vol. 8, no. 2, 2018, art. no. e018524 - SCI ; SCOPUS

[o1] 2018 Ofori-Asenso, R. - Jakhu, A. - Curtis, A.J. - Zomer, E. - Gambhir, M. - Jaana Korhonen, M. - Nelson, M. - Tonkin, A. - Liew, D. - Zoungas, S.: Journals of Gerontology - Series A Biological Sciences and Medical Sciences, vol. 73, no.6, 2018, s. 798-805 - SCI ; SCOPUS

[o1] 2018 Yuan, H.W. - Ji, R.J. - Lin, Y.J. - Chen, H.F. - Peng, G.P. - Luo, B.Y.: Clinical Therapeutics, vol. 40, no. 12, 2018, s. 2041-2049 - SCI ; SCOPUS

[o1] 2019 Ofori-Asenso, R. - Ilomäki, J. - Tacey, M. - Si, S. - Curtis, A.J. - Zomer, E. - Bell, J.S. - Zoungas, S. - Liew, D.: British Journal of Clinical Pharmacology, vol. 85, no. 1, 2019, s. 227-235 - SCI ; SCOPUS

[o1] 2019 Yang, Z. - Edwards, D. - Massou, E. - Saunders, C.L. - Brayne, C. - Mant, J.: Clinical Epidemiology, vol. 11, 2019, s. 495-508 - SCI ; SCOPUS

[o1] 2019 Bezin, J. - Moore, N.: Therapie, vol. 74, no. 2, 2019, s. 261-269 - SCI ; SCOPUS

[o1] 2019 Alwhaibi, M. - Altoaimi, M. - AlRuthia, Y. - Meraya, A.M. - Balkhi, B. - Aldemerdash, A. - Alkofide, H. - Alhawassi, T.M. - Alqasoumi, A. - Kamal, K.M.: Patient Preference and Adherence, vol. 13, 2019, s. 2111-2118 - SCI ; SCOPUS

[o1] 2020 Jang, D.E. - Zuniga, J.A.: Neurological Research, vol. 42, no. 7, 2020, s. 537-546 - SCOPUS

4

[o1] 2017 Pan, J. - Lei, T. - Hu, B. - Li, Q.: Patient Preference and Adherence, Vol. 11, 2017, s. 1922 - SCOPUS

[o1] 2018 Dal-Re, R. - Janiaud, P. - Ioannidis, J.P.A.: BMC Medicine, Vol. 16, No. 1, 2018, art. no. 49 - SCOPUS

[o1] 2018 Jiang, C. - Zhang, H. - Liu, K. - Zheng, S. - Yang, Y. - Tian, F. - Feng, C.: 2018 IEEE 20th International Conference on e-Health Networking, Applications and Services, Healthcom 2018, art. no. 8531179 - SCOPUS

[o1] 2019 Kim, M.: Iranian Journal of Public Health, Vol. 48, No. 4, 2019, s. 663 - SCOPUS

[o1] 2019 Zetzl, T. - Schuler, M. - Renner, A. - Jentschke, E. - Van Oorschot, B.: BMC Psychology, Vol. 7, No. 1, 2019, art. no. 64 - SCOPUS

[o1] 2019 Anwar, V.A. - Hasan, D. - Keban, S.A. - Saibi, Y.: Indian Journal of Public Health Research and Development, Vol. 10, No. 7, 2019, s. 728 - SCOPUS

[o1] 2019 Singh, N. - Varshney, U.: International Journal of Electronic Healthcare, Vol. 11, No. 1, 2019, s. 44 - SCOPUS

[o1] 2020 Ravari, A. - Irani, M. - Mirzaei, T. - Raeisi, M. - Majdabadi, H.A.: Koomesh, Vol. 22, No. 3, 2020, s. 445 - SCOPUS

[o1] 2020 Etminani, K. - Engstrom, A.T. - Goransson, C. - Sant anna, A. - Nowaczyk, S.: Journal of Medical Internet Research, Vol. 22, No. 4, 2020, art. no. e17201 - SCOPUS

[o1] 2020 Pour, E.R. - Aliyari, S. - Farsi, Z. - Ghelich, Y.: Nursing and Midwifery Studies, Vol. 9, No. 2, 2020, s. 76 - SCOPUS

[o1] 2020 Zhai, P. - Hayat, K. - Ji, W. - Li, Q. - Shi, L. - Atif, N. - Xu, S. - Li, P. - Du, Q. - Fang, Y.: Journal of Medical Internet Research, Vol. 22, No. 5, 2020, art. no. e16019 - SCOPUS

[o1] 2020 Cross, A.J. - Elliott, R.A. - Petrie, K. - Kuruvilla, L. - George, J.: Cochrane Database of Systematic Reviews, Vol. 2020, No. 5, 2020, art. no. CD012419 - SCOPUS

5

[o1] 2018 Zhang, F. - Finkelstein, J.: Potential effect of suboptimal racial and ethnic categorization on benefits of precision medicine. In: 9th IEEE Annual Ubiquitous Computing, Electronics and Mobile Communication Conference, UEMCON 2018,art. no. 8796539. [s.l.] : Institute of Electrical and Electronics Engineers, 2018, s. 778 - SCOPUS

[o1] 2019 Zhang, F. - Finkelstein, J.: Pharmacogenomics and Personalized Medicine, Vol. 12, 2019, s. 123 - SCOPUS

[o1] 2020 Tachkov, K. - Vassilev, A. - Kostova, S.: Frontiers in Public Health, Vol. 7, 2020, art. no. 363 - SCOPUS

[o1] 2020 Mela, A.K.: Acta Poloniae Pharmaceutica - Drug Research, Vol. 77, No. 5, 2020, s. 280 - SCOPUS

[o1] 2020 Cazacu, I. - Fourrier-Réglat, A. - Haramburu, F. - Mogosan, C. - Gheorghe-Cetean, S. - Vostinaru, O. - Loghin, F.: Farmacia, Vol. 68, No. 5, 2020, s. 943 - SCOPUS

[o1] 2020 Salmane-Kulikovska, I. - Poplavska, E. - Mezinska, S. - Dumpe, V. - Dauvarte, H. - Lazdina, L. - Marchockij, A. - Varzinskas, K. - Mintzes, B.J.: BMC Medical Education, Vol. 20, No. 1, 2020, art. no. 105 - SCOPUS

[o1] 2020 Pavelka, K. - Szekanecz, Z. - Damjanov, N. - Anic, B. - Tomšič, M. - Mazurov, V. - Maksimovic, M. - Nagy, O. - Swierkot, J. - Petranova, T. - Veldi, T. - Baranauskaite, A. - Codreanu, C. - Andersone, D. - Fleischmann, R.: Drugs inContext, Vol. 9, 2020, art. no. 2020-7-5 - SCOPUS

VI.5 - Participation in conducting (leading) the most important research projects or art projects over the last six years
1

EUnetHTA Joint Action 3 (2016 - 2021): The aim of the project was to define and implement a sustainable model for scientific and technical cooperation in health technology assessment (HTA) in Europe. HTA is a multidisciplinary process that uses explicit methods to determine the value of healthcare technology at various points in its life cycle. The purpose is to inform decision-making processes in order to promote a fair, efficient and high-quality healthcare system. Medical technology is an intervention developed to prevent, diagnose or treat medical conditions; health promotion; provision of rehabilitation; or organizing the provision of healthcare. An intervention can be a test, device, drug, vaccine, procedure, program, or system. The process is formal, systematic and transparent, and state-of-the-art evidence is used to consider the best available methods. The dimensions of value for health technology can be assessed by examining the intended and unintended consequences of using health technology in comparison with existing alternatives. These dimensions often include clinical efficacy, safety, cost and economic implications, ethical, social, cultural, legal issues, organizational, environmental aspects, as well as broader implications for the patient, relatives, carers and the population. The overall value may vary depending on the perspective, stakeholders and context of decision-making. HTA can be applied at various points in the life cycle of a medical technology, ie before it is placed on the market, during its approval, after it is placed on the market and after the disinvestment of the medical technology. This project has set up an effective European network bringing together HTA agencies, research institutions and ministries of health, enabling effective information exchange and decision support on the use of health technologies in EU Member States. 81 organizations from 29 countries participated in the cooperation.

2

Central and Eastern European Pharmaco-Epidemiology (CEEPHE) Data Research Group, which succeeded in 2021 on the basis of a tender (EMA / 2020/46 / TDA - Quality, efficacy and safety studies on medicines) to support regulatory decision-making in the regulatory field of medicinal products for human use, which was sent to the European Medicines Agency (EMA). CEEPHE can make a vital contribution to addressing the quality, efficacy and safety of medicines from real clinical practice during the 4-year period of the European Medicines Agency project (EMA / 2020/46 / TDA - Quality, efficacy and safety studies on medicines). The results of analyzes of data from various health registries and health insurance companies, which we refer to as Real World Data (RWD), can significantly improve knowledge about the safety and efficacy of new drugs. RWD data should be considered as complementary information that complements the results of a clinical trial of drugs. As this case involves cooperation within several member states of the European Union, the above statistical and epidemiological analyzes will improve the decision-making processes for reimbursement of medicines from public health insurance not only in the Slovak Republic but also within the member states of the European Union.

3

The European Surveillance of Antimicrobial Consumption Network (ESAC-Net), which is a Europe-wide network of national surveillance systems providing European reference data on the consumption of antimicrobials. Since 2011, the European Center for Disease Prevention and Control (ECDC) has been responsible for coordinating the collection of antibiotic consumption data from EU / EEA countries and uses the European Antimicrobial Consumption Monitoring Network (ESAC-Net). This role of the ECDC is supported by Decision No. 1082/2013 / EU on serious cross-border threats to health.

4

APVV-18-0425: Entry and competition on regulated markets: functioning of the Slovak pharmaceutical market (2019 - 2023).

The project is implemented in cooperation with the Faculty of National Economy of the University of Economics in Bratislava and is focused on reviewing competition, market entry and regulation of the pharmaceutical market in Slovakia. In addition to gaining specific knowledge about the functioning of the Slovak pharmacy market, the project contributes in several ways to the current state of knowledge from a global perspective. Spatial interactions between individual pharmacies are explicitly modeled in the project. The project also deals with substitution and complementary relationships in the pharmaceutical market and its interactions with healthcare providers. In addition, the effects of different types of regulation on companies' market entry and location decisions are modeled.

5

VEGA 1/0024/21: Possibilities of pharmacoepidemiological analysis of adherence to preventive pharmacotherapy in elderly patients with peripheral arterial disease of the lower extremities.

The project is implemented in cooperation with the Institute of Pharmacology and Clinical Pharmacology, Faculty of Medicine, Comenius University in Bratislava. Peripheral arterial disease of the lower extremities (PAO) leads to ischemia and thrombotic complications in the arterial artery of the extremities and is accompanied by an increased risk of cardiovascular events. Secondary prevention of PAOs involves the treatment of modifiable risk factors (arterial hypertension, diabetes mellitus, dyslipidemia) and the administration of antiplatelet agents, angiotensin-converting enzyme inhibitors and statins. The basic precondition for the success of secondary prevention is the adherence of patients to prescribed drugs. The aim of the project is a pharmacoepidemiological analysis of the adherence of elderly patients with PAO to preventive pharmacotherapy at the level of implementation and persistence. We identify patient factors that affect the risk of non-persistence and poor implementation as assessed by the "proportion of days covered by treatment" parameter. The obtained results will make it possible to define groups of patients who require increased attention in terms of improving their adherence to prescription drugs.

VII. - Overview of organizational experience related to higher education and research/artistic/other activities

VIII. - Overview of international mobilities and visits oriented on education and research/artistic/other activities in the given field of study

IX. - Other relevant facts

IX.a - If relevant, other activities related to higher education or research/artistic/other activities are mentioned

Expert, registered at the Ministry of Justice of the Slovak Republic for the area of Pharmacy (performs expert activity, which consists mainly of pharmaceutical and forensic assessment of specific circumstances of the case with emphasis on all pharmaceutical contexts of the case, focuses mainly on expert opinions for law enforcement agencies, courts, legal persons and natural persons).

Date of last update
2025-01-09